Estimated distribution of colorectal cancer stage among patients assumed to have missed diagnosis in 2011 (unit: persons). by Hiroaki Saito (24514)

Subjects:

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Additional loss of life expectancy and cost per life-year saved resulting from changes in colorectal cancer stage due to a 1-year diagnostic delay. by Hiroaki Saito (24514)

Subjects:

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Preoperative background characteristics of the patients. by Yasuyuki Sotani (20114144)

Subjects:

Higher sampling flow rates result in higher viral recovery. by Eloise Parry-Nweye (7548998)

Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”

Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”

Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”

Cluster analysis results based on the AAPC values of the age-standardized rates for deaths and DALYs attributed to SAH burden in the global AYA population from 1990 to 2021. by Xuanchen Liu (12188147)

“…Regions are classified into four categories: remained stable or minor decrease (blue), moderate decrease (light blue), substantial decrease (yellow), and significant decrease (red). …”

Alterations of Ceramides, Acylcarnitines, GlyceroLPLs, and Amines in NSCLC Tissues by Jie Zhang (64655)

Subjects:

The speed diagram. by Yifei Li (198040)

Subjects:

Factors of orthogonal experiment. by Yifei Li (198040)

Subjects:

Analysis of variance in orthogonal test. by Yifei Li (198040)

Subjects:

Comparison between simulation tests and bench tests. by Yifei Li (198040)

Subjects:

Schematic diagram of the millet characteristic dimensions. by Yifei Li (198040)

Subjects:

Structure and collision diagram of the millet hole seeding system. by Yifei Li (198040)

Subjects:

Analysis of variance in orthogonal test. by Yifei Li (198040)

Subjects:

Comparison between simulation tests and bench tests. by Yifei Li (198040)

Subjects:

Comparison between simulation tests and bench tests. by Yifei Li (198040)

Subjects: